The use of combination therapy by a single-dosage form
allows patients to achieve their blood pressure goal quickly, improves
adverse drug reactions, and is supported by prospective data.
Beginning in 2010, the pharmaceutical
industry faced one of the biggest waves of drug patent expirations in
history, a phenomenon referred to as the “patent cliff.”
Addressing supply interruptions requires collaboration and
guidelines to manage patient care, especially in the midst of highly
specialized medication regimens.
The increased use of generic medications is an important
strategy in managing overall pharmaceutical spending, especially by
Medicaid and other government-run health programs.